EU's CHMP recommends label extensions for Viread, Arixtra and M-M-RVAXPRO
This article was originally published in Scrip
Executive Summary
The EU's CHMP has endorsed label extensions for Sanofi Pasteur's MMR vaccine M-M-RVAXPRO, Gilead Sciences' antiviral Viread (tenofovir disoproxil fumarate), and GlaxoSmithKline's Factor Xa inhibitor Arixtra (fondaparinux sodium) in its July monthly meeting.